Disease management for depression in an MS clinic

International Journal of Psychiatry in Medicine

Volumn 37, Issue 4, 2007, Pages 459-473

  Patten, Scott B ^a   Newman, Stephen ^b   Becker, Melodie ^a   Riddell, Catherine ^a   Metz, Luanne ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Depressive disorders; Disease management; Multiple sclerosis; Prospective study; Screening

Indexed keywords

ADULT; ARTICLE; DEPRESSION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHIATRY; QUALITY OF LIFE; RATING SCALE;

ACTIVITIES OF DAILY LIVING; ADULT; ALBERTA; ANTIDEPRESSIVE AGENTS; ATTITUDE TO HEALTH; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MULTIPLE SCLEROSIS; PERSONALITY INVENTORY; PROSPECTIVE STUDIES; PSYCHOTHERAPY; QUALITY OF LIFE; RECURRENCE; REFERRAL AND CONSULTATION; SOCIOECONOMIC FACTORS;

EID: 41549116270     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/PM.37.4.h     Document Type: Article

References (44)

1. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: Epidemiological study of a large community sample. American Journal of Psychiatry 2002;159:1862-1868.
2. Sollom AC, Kneebone II. Treatment of depression in people who have multiple sclerosis. Multiple Sclerosis 2007;13:632-635.
3. Patten SB, Beck CA, Williams JVA, Barbui C, Metz L. Major depression in multiple sclerosis: A population-based perspective. Neurology 2003;61:1524-1527.
4. Wang JL, Reimer MA, Metz LM, Patten SB. Major depression and quality of life in individuals with multiple sclerosis. International Journal of Psychiatry in Medicine 2000;30:309-317.
5. Benedict RHB, Wahlig E, Bakshi R, Fishman I, Munschauer F, Zivadinov R, Weinstock-Guttman B. Predicting quality of life in multiple sclerosis: Accounting for physical disability, fatigue, cognition, mood disorder, personality and behavior change. Journal of the Neurological Sciences 2005;231:29-34.
6. Lobentanz IS, Asenbaum S, Vass K, Sauter C, Klösch G, Kollegger H, Kristoferitsch W, Zeitlhofer J. Factors influencing quality of life in multiple sclerosis: Disability, depressive mood, fatigue and sleep quality. Acta Neurologica Scandinavica 2004;110:6-13.
7. D'Alisa S, Miscio G, Baudo S, Simone A, Tesio L, Mauro A. Depression is the main determinant of quality of life in multiple sclerosis: Aclassification-regression analysis. Disability and Rehabilitation 2006;28:307-314.
8. Janssens ACJW, van Doorn PA, de Boer JB, Kalkers NF, van der Meché FGA, Passchier J, Hintzen RQ. Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Multiple Sclerosis 2003; 9:397-403.
9. Hart S, Fonareva I, Merluzzi N, Mohr DC. Treatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients. Quality of Life Research 2005;14:695-703.
10. Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA. Treatment of depression improves adherence to interferon b-1b therapy for multiple sclerosis. Archives of Neurology 1997;54:531-533.
11. Feinstein A. An examination of suicidal intent in patients with multiple sclerosis. Neurology 2002;59:674-678.
12. Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP. Treatment of depression is associated with suppression of nonspecific and antigen-specific T-H1 responses in multiple sclerosis . Archives of Neurology 2001;58:1081-1086.
13. Mohr DC, Goodkin DE, Likosky W, Beutler L, Gatto N, Langan MK. Identification of Beck Depression Inventory items related to multiple sclerosis. Journal of Behavioral Medicine 1997;20:407-414.
14. Aikens JE, Reinecke MA, Pliskin NH, Fischer JS, Wiebe JS, McCracken LM, Taylor JL. Assessing depressive symptoms in multiple sclerosis: Is it necessary to omit items from the original Beck Depression Inventory? Journal of Behavioral Medicine 1999;22:127-141.
15. Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. Journal of Consulting and Clinical Psychology 2001;69:942-949.
16. Barak Y, Ur E, Achiron A. Moclobemide treatment in multiple sclerosis patients with comorbid depression: An open-label safety trial. Journal of Neuropsychiatry and Clinical Neuroscience 1999;11:271-273.
17. Scott TF, Allen D, Price TRP, McConnell H, Lang D. Characterization of major depression symptoms in multiple sclerosis patients. Journal of Neuropsychiatry 1996;8:318-323.
18. Schiffer RB, Wineman NM. Antidepressant pharmacotherapy of depression associated with multiple sclerosis. American Journal of Psychiatry 1990;147: 1493-1497.
19. The Goldman Consensus Conference Participants, National MS Society. The Goldman Consensus Statement on Mood Disorders in Multiple Sclerosis. Multiple Sclerosis 2005;11:328-337.
20. Kates N, Mach M. Chronic disease management for depression in primary care: A summary of the current literature and implications for practice. Canadian Journal of Psychiatry 2007;52:77-85.
21. Mohr DC, Hart SL, Tasch ES. Screening for depression among patients with multiple sclerosis: Two questions may be enough. Multiple Sclerosis 2007;13:215-219.
22. Neumeyer-Gromen A, Lampert T, Stark K, Kallischnigg G. Disease management programs for depression. A systematic review and meta-analysis of randomized controlled trials. Medical Care 2004;42:1211-1221.
23. Tutty S, Simon G, Ludman E. Telephone counseling as an adjunct to antidepressant treatment in in the primary care system. A pilot study. Effective Clinical Practice 2000;3:170-178.
24. Simon GE, Ludman EJ, Tutty S, Operskalski B, Von Korff M. Telephone psychotherapy and telephone care management for primary care patients starting antidepressant treatment. A randomized controlled trial. Journal of the American Medical Association 2004;292:935-942.
25. Hunkeler EM, Meresman JF, Hargreaves WA, Fireman B, Berman WH, Krisch AJ, Groebe J, Hurt SW, Braden P, Getzell M, Feigenbaum PA, Peng T, Salzer M. Efficacy of Nurse telehealth care and peer support in augmenting treatment of depression in primary care. Archives of Family Medicine 2000;9:700-708.
26. Mohr DC, Hart SL, Julian L, Catledge C, Honos-Webb L, Vella L, Tasch ET. Telephone-administered psychotherapy for depression. Archives of General Psychiatry 2005;62:1007-1014.
27. Banerjee S, Shamash K, MacDonald AJD, Mann AH. Randomised controlled trial of effect of intervention by psychogeriatric team on depression in frail elderly people at home. British Medical Journal 1996;313:1058-1061.
28. Llewellyn-Jones RH, Baikie KA, Smithers H, Cohen J, Snowdon J, Tennant CC. Multifaceted shared care intervention for late life depression in residential care: Randomised controlled trial. British Medical Journal 1999;319:676-682.
29. Lin EHB, Simon GE, Katon WJ, Russo JE, Von Korff M, Bush TM, Ludman EJ, Walker AE. Can enhanced acute-phase treatment of depression improve long-term outcomes? A report of randomized trials in primary care. American Journal of Psychiatry 1999;156:643-645.
30. Unützer J, Katon W, Williams JW, Callahan CM, Harpole L, Hunkeler EM, Hoffing M, Arean P, Hegel MT, Schoenbaum M, Oishi SM, Langston CA. Improving primary care for depression in late life. The design of a multicenter randomized trial. Medical Care 2001;8:785-799.
31. Hunkeler EM, Katon W, Tang L, Williams JW, Kroenke K, Lin EHB, Harpole LH, Arean P, Levine S, Grypma LM, Hargreaves WA, Unützer J. Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care. British Medical Journal 2006;332:259-263.
32. Katon WJ, Von Korff M, Lin EHB, Simon G, Ludman E, Russo J, Ciechanowski P, Walker E, Bush T. The Pathways study. Archives of General Psychiatry 2004; 61:1042-1049.
33. Aikens JE, Fischer JS, Namey M, Rudick RA. A replicated prospective investigation of life stress, coping, and depressive symptoms in multiple sclerosis. Journal of Behavioral Medicine 1997;20:433-445.
34. Foley FW, Bedell JR, LaRocca NG, Scheinberg LC, Reznikoff M. Efficacy of stress-inoculation training in coping with multiple sclerosis. Journal of Consulting and Clinical Psychology 1987;55:919-922.
35. Arnett PA, Higginson CI, Voss WD, Randolph JJ, Grandey AA. Relationship between coping, cognitive dysfunction and depression in multiple sclerosis. Clinical Neuropsychologist 2002;16:341-355.
36. Mynors-Wallis LM, Gath DH, Lloyd-Thomas AR, Tomlinson D. Randomized controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. British Medical Journal 1995;310:441-445.
37. Dowrick C, Dunn G, Ayuso-Mateos JL, Dalgard OS, Page H, Lehtinen V, Casey P, Wilkinson C, Vazquez-Barquero JL, Wilkinson G. Problem solving treatment and group psychoeducation for depression: Multicentre randomised controlled trial. British Medical Journal 2000;321:1450-1454.
38. Svenson LW, Woodhead SE, Platt GH. Regional variations in the prevalence rates of multiple sclerosis in the province of Alberta, Canada. Neuroepidemiology 1994;13:8-13.
39. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. Validity of a brief depression severity measure. Journal of General Internal Medicine 2001;16:606-613.
40. Lecubier Y, Sheehan DV, Weiller E, Amorim P, Bonora I, Sheehan KH, Janavs J, Dunbar GC. The MINI International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: Reliability and validity according to the CIDI. European Psychiatry 1997;12:224-231.
41. Montel SR, Bungener C. Coping and quality of life in one hundred and thirty-five subjects with multiple sclerosis. Multiple Sclerosis 2007;13:393-401.
42. Epping-Jordan, J. The WHODAS II. Geneva, Switzerland, The World Health Organization, 2000.
43. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability scale (EDSS). Neurology 1983;33:1444-1452.
44. Fisk JD, Brown MG, Sketris IS, Metz LM, Murray TJ, Stadnyk KJ. A comparison of health utility measures for the evaluation of multiple sclerosis treatments. Journal of Neurology Neurosurgery and Psychiatry 2005;76:58-63.